Radiant Sage receives Customer Value Enhancement Award from Frost & Sullivan

Monday, August 20, 2012 03:27 PM

Radiant Sage, a provider of on-demand clinical trial image management solutions based in Belmont, Mass., has received the Frost & Sullivan 2012 Customer Value Enhancement Award for its clinical trial image management solutions.

The award recognizes companies that have demonstrated excellence in implementing strategies and supporting products and services that proactively create value for their customers, with a focus on improving the return on investment that customers make in their products or services.

"We are honored to receive this prestigious award from Frost & Sullivan," said Venkatesan Thangaraj, CEO of Radiant Sage. "We have partnered with top global pharmaceutical companies to develop our clinical trial image management solutions to specifically meet their needs and the industry in general. This award validates our efforts to focus on the customer and the value we bring to their organization by simplifying the image management process for clinical trial sponsors and enabling them to quickly and cost-effectively develop drugs."

Jennifer Brice, global program manager of life sciences, Frost & Sullivan, said, "Radiant Sage's solutions were brought to the market specifically for clinical imaging trials. Its products and services enable its customers to take control over imaging trials in a seamless fashion. It is for these reasons that we presented Radiant Sage with this award."

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs